ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GDR Genedrive Plc

1.625
-0.125 (-7.14%)
27 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Genedrive Plc LSE:GDR London Ordinary Share GB00B1VKB244 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.125 -7.14% 1.625 1.60 1.65 1.75 1.525 1.75 63,456,389 16:19:22
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 55k -5.15M -0.0095 -1.71 8.8M
Genedrive Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker GDR. The last closing price for Genedrive was 1.75p. Over the last year, Genedrive shares have traded in a share price range of 1.425p to 17.50p.

Genedrive currently has 543,141,481 shares in issue. The market capitalisation of Genedrive is £8.80 million. Genedrive has a price to earnings ratio (PE ratio) of -1.71.

Genedrive Share Discussion Threads

Showing 6326 to 6349 of 27050 messages
Chat Pages: Latest  254  253  252  251  250  249  248  247  246  245  244  243  Older
DateSubjectAuthorDiscuss
09/2/2021
15:33
Not a nice feeling for those that bought, seeing NT to sell
oilisgold
09/2/2021
15:32
That's their own fault if they panicked and soldAnyone who has done any research will know to hold until figures for BC become clearer
hooded claw
09/2/2021
15:28
not a nice feeling if some have sold out and now being quoted N T to buy in again



especially as getting closer to mid February


The Genedrive® 96 SARS-CoV-2 test is ideally suited for use on the high throughput robotic Biomek i7 instrument. The ready-to-go nature of the test removes many of the fluid dispensing steps required in competitor assays, increasing the overall throughput of the Biomek compared to using a liquid reagent based test formulation. Full automation of the overall PCR workflow can allow laboratories to run large numbers of tests over extended working hours or workstation platforms. Beckman Coulter estimates that this new turnkey solution could process circa 1,000 PCR samples per Biomek workstation installed during a standard 8-hour working day, using just a 0.5 full-time-equivalent in technician time for processing.



David Budd, CEO of genedrive plc, said: "We are very pleased to have the partnership of Beckman Coulter in accessing significant COVID testing opportunities throughout the United States and Europe, where the incidence of COVID continues to escalate and the need for high throughout testing solutions remains a priority. The combination of genedrive and Beckman Coulter products and expertise provides the Company with a new, innovative, and competitive solution, and a new sales channel for the American market, which we did not have previously.



"We are very pleased to now take our initial collaboration and development agreement to the commercial stage. Beckman Coulter is an important and significant company in these core geographies, well suited to promoting, selling, and supporting our products."



The Companies are planning commercial introduction of the Genedrive kit from mid February, following commercial and technical training of the Beckman sale and support organisations

bunz3
09/2/2021
15:25
with NT to buy some who have sold might not be so pleased if they finding it difficult to buy back in again ,if mms are running low with share supply
bunz3
09/2/2021
15:22
Richard, answer my question fool. Rns was it from a buyer?
oilisgold
09/2/2021
15:21
Non stop selling. Sellers still selling
oilisgold
09/2/2021
15:21
He is a loser working for nobody. Sold too early now is green with envy
richardp19
09/2/2021
15:21
Richard, was the RNS stating a buyet?
oilisgold
09/2/2021
15:20
Soo many sellers selling. RNS was off a seller not a buyer
oilisgold
09/2/2021
15:20
Very easy to sell you clown as you wouldn't know because you dnt own anyo shares
richardp19
09/2/2021
15:20
Sellers not letting tjis rise. NT TO SELL AGAIN
oilisgold
09/2/2021
15:19
Mote buyets now
oilisgold
09/2/2021
15:18
if rns is released ,and if mms look to be running low with share supply be interesting to see how much they move share price up
bunz3
09/2/2021
15:18
I do and I've been scaling in every day for the last week!
actybod
09/2/2021
15:18
Oil working for his master so he can buy in lower.Best to filter it.
hooded claw
09/2/2021
15:16
you can sell ,not so easy to buy ,


they looking to be running low with share supply



is a rns close

bunz3
09/2/2021
15:16
Actybod, you clearly have no idea what is coming.All you see is the rise.What you should see is the market cap.
hooded claw
09/2/2021
15:10
After such a rise?
actybod
09/2/2021
15:08
its would be a dream come true if DB gets out an RNS at this moment !!
pal44
09/2/2021
15:06
Well hope shorters get caught out by a big juicy rns from budd!
yasyas1
09/2/2021
15:05
Was hoping for this to stabilise around £1.5. Dissapointing drop
yasyas1
09/2/2021
15:03
looking strong for a good finish,will another rns be released before end of trading then two TR1 yesterday afternoon
bunz3
09/2/2021
15:00
Sellers 4 to 1
oilisgold
09/2/2021
14:59
We dropped from 140p to 129p. Worrying times. At this rate we be in red
oilisgold
Chat Pages: Latest  254  253  252  251  250  249  248  247  246  245  244  243  Older